Although immunotherapy has not been carried out in CRC widespread, it was shown that GADD45B could modulate innate immune checkpoint functions, which are amenable to therapeutic intervention to reprogram tumor-associated macrophages and ultimately overcome tumor microenvironments dependent on immunosuppression [17,21]. This evidence concerns the gene GADD45B and neoplasm.